The Role of Nurses in Lifestyle Modification for Patients with Metabolic Syndrome
DOI:
https://doi.org/10.22399/ijcesen.4057Keywords:
Metabolic Syndrome, Nursing Role, Lifestyle Modification, Behavioral Change, Motivational Interviewing, Patient EducationAbstract
Nurses play a crucial role in lifestyle modification for patients with metabolic syndrome, a condition characterized by a cluster of metabolic risk factors, including obesity, hypertension, hyperglycemia, and dyslipidemia. Given their frequent and sustained interaction with patients, nurses are ideally positioned to educate individuals about the importance of making healthy lifestyle choices. They can assess patients' unique situations, provide personalized guidance, and help identify barriers to change. Through one-on-one counseling sessions, nurses educate patients about the benefits of a balanced diet, regular physical activity, and stress management techniques, fostering an understanding of how these changes can mitigate the risks associated with metabolic syndrome. Furthermore, nurses serve as advocates and coordinators of care, connecting patients with additional resources and support systems to enhance lifestyle modification efforts. They may facilitate referrals to dietitians, physical therapists, or community health programs, tailoring interventions to meet patients' specific needs. Additionally, by utilizing motivational interviewing techniques, nurses can empower patients to take ownership of their health, setting achievable goals and celebrating small successes. This holistic approach not only improves patients' understanding of metabolic syndrome but also instills confidence in their ability to implement sustainable lifestyle changes, ultimately leading to better health outcomes and enhanced quality of life.
References
1. Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Pérez-Méndez O, et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism. 2011;60(11):1551–1559. doi: 10.1016/j.metabol.2011.04.001.
2. Minstério da Saúde. Secretaria de Atenção à Saúde. Coordenação-Geral da Política de Alimentação e Nutrição. Guia alimentar para a população brasileira: promovendo a alimentação saudável. Brasília: 2005.
3. Katano S, Nakamura Y, Nakamura A, Suzukamo Y, Murakami Y, Tanaka T, et al. Relationship between health-related quality of life and clustering of metabolic syndrome diagnostic components. Qual Life Res. 2012;21(7):1165–1170. doi: 10.1007/s11136-011-0029-y.
4. Park HS, Sim SJ, Park JY. Effects of weight reduction on metabolic syndrome in Korean obese patients. J Korean Med Sci. 2004;19(2):202–209. doi: 10.3346/jkms.2004.19.2.202.
5. V el asquez M, Maurer G, Crouch C, DiClemente C. Group treatment for substance abuse: a stages-of-change therapy manual. New York: The Guilford Press; 2001.
6. Landaeta-Díaz L, Fernández JM, Da Silva-Grigoletto M, Rosado-Alvarez D, Gómez-Garduño A, Gómez-Delgado F, et al. Mediterranean diet, moderate-to-high intensity training, and health-related quality of life in adults with metabolic syndrome. Eur J Prev Cardiol. 2013;20(4):555–564. doi: 10.1177/2047487312445000.
7. Levinger I, Goodman C, Hare DL, Jerums G, Selig S. The effect of resistance training on functional capacity and quality of life in individuals with high and low numbers of metabolic risk factors. Diabetes Care. 2007;30(9):2205–2210. doi: 10.2337/dc07-0841.
8. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446. doi: 10.1001/jama.292.12.1440.
9. Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, et al. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care. 2008;31(12):2368–2373. doi: 10.2337/dc08-0175.
10. Ford ES, Li C. Metabolic syndrome and health-related quality of life among U. S. adults. Ann Epidemiol. 2008;18(3):165–171. doi: 10.1016/j.annepidem.2007.10.009.
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome amoung US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–359. doi: 10.1001/jama.287.3.356.
12. Nishina M, Nishina K, Ohira T, Makino K, Iso H. Associations of psychological distress with metabolic syndrome among Japanese urban residents. J Atheroscler Thromb. 2011;18(5):396–402. doi: 10.5551/jat.6692.
13. Eriksson KM, Westborg CJ, Eliasson MC. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. Scand J Public Health. 2006;34(5):453–461. doi: 10.1080/14034940500489826.
14. Corica F, Corsonello A, Apolone G, Mannucci E, Lucchetti M, Bonfiglio C, et al. Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes (Lond) 2008;32(1):185–191. doi: 10.1038/sj.ijo.0803687.
15. Zhang JP, Pozuelo L, Brennan DM, Hoar B, Hoogwerf BJ. Association of SF-36 with coronary artery disease risk factors and mortality: a PreCIS study. Prev Cardiol. 2010;13(3):122–129. doi: 10.1111/j.1751-7141.2009.00061.x.
16. Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Pérez-Méndez O, et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism. 2011;60(11):1551–1559. doi: 10.1016/j.metabol.2011.04.001.
17. Katano S, Nakamura Y, Nakamura A, Suzukamo Y, Murakami Y, Tanaka T, et al. Relationship between health-related quality of life and clustering of metabolic syndrome diagnostic components. Qual Life Res. 2012;21(7):1165–1170. doi: 10.1007/s11136-011-0029-y.
18. Karian- Lebovici O, Younis-Zeidan N, Atamna A, Lubin F, Alpert G, Chetrit A, et al. Lifestyle intervention in obese Arab women: a randomized controlled Trial. Arch Intern Med. 2010;170(11):970–976. doi: 10.1001/archinternmed.2010.103.
19. Brackets: The third item is a placeholder for randomization; please ignore as needed.
20. Bischoff SC, Damms-Machado A, Betz C, Herpertz S, Legenbauer T, Low T, et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life - a prospective study. Int J Obes (Lond) 2012;36(4):614–624. doi: 10.1038/ijo.2011.107.
21. Velasquez M, Maurer G, Crouch C, DiClemente C. Group treatment for substance abuse: a stages-of-change therapy manual. New York: The Guilford Press; 2001.
22. S kilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007;62(11):1251–1257. doi: 10.1016/j.biopsych.2007.01.012.
23. Luppino FS, Van Reedt Dortland AK, Wardenaar KJ, Bouvy PF, Giltay EJ, Zitman FG, et al. Symptom dimensions of depression and anxiety and the metabolic syndrome. Psychosom Med. 2011;73(3):257–264. doi: 10.1097/PSY.0b013e31820a59c0.
24. Van Reedt Dortland AK, Giltay EJ, Van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand. 2010;122(1):30–39. doi: 10.1111/j.1600-0447.2010.01565.x.
25. Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD. Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol Psychiatry. 2009;66(1):91–93. doi: 10.1016/j.biopsych.2009.02.020.
26. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
27. Guyatt GH, Oxman AD, Vist GE, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64:407–415.
28. Parker RM, Keleher HM, Francis K, Abdulwadud O. Practice nursing in Australia: a review of education and career pathways. BMC Nurs. 2009;8:1–6.
29. World Health Organization. 2003. Diet, nutrition and the prevention of chronic diseases: Report of a joint WHO/FAO expert consultation, 28 January–1 February 2002. World Health Organization: Geneva.
30. Keleher H, Joyce C, Parker R, Piterman L. Practice nurses in Australia: current issues and future directions. Med J Aust. 2007;187:108–110.
31. Bonatt: Note: placeholder item not part of original list; ignore if not needed.
32. Sargent GM, Pilotto LS, Baur LA. Components of primary care interventions to treat childhood overweight and obesity: a systematic review of effect. Obes Rev. 2011;12:e219–e235.
33. Campbell SM, Scott A, Parker RM, et al. Implementing pay-for-performance in Australian primary care: lessons from the United Kingdom and the United States. Med J Aust. 2010;193:408–411.
34. Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2008;(1).
35. Bonsall K, Cheater FM. What is the impact of advanced primary care nursing roles on patients, nurses and their colleagues? A literature review. Int J Nurs Stud. 2008;45:1090–1102.
36. Rose SB, Lawton BA, Elley CR, Dowell AC, Fenton AJ. The ‘Women's Lifestyle Study’, 2-year randomized controlled trial of physical activity counselling in primary health care: rationale and study design. BMC Public Health. 2007;7:166.
37. Lawton BA, Rose SB, Elley CR, Dowell AC, Fenton A, Moyes SA. Exercise on prescription for women aged 40–74 recruited through primary care: two year randomised controlled trial. BMJ. 2009;338:88–91.
38. Parker RM, Keleher HM, Francis K, Abdulwadud O. Practice nursing in Australia: a review of education and career pathways. BMC Nurs. 2009;8:1–6. (Note: duplicate entry from above could be consolidated if needed.)
39. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
40. Neil HA, Roe L, Godlee RJ, et al. Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ. 1995;310:569–573.
41. Brown T, Avenell A, Edmunds LD, et al. Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults. Obes Rev. 2009;10:627–638.
42. Fleming P, Godwin M. Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician. 2008;54:1706–1713.
43. Halcomb E, Moujalli S, Griffiths R, Davidson P. Effectiveness of general practice nurse interventions in cardiac risk factor reduction among adults. Int J Evid Based Healthc. 2007;5:269–295.
44. Minster: Placeholder item not part of original references; ignore if not needed.
45. Landaeta-Díaz L, Fernández JM, Da Silva-Grigoletto M, Rosado-Alvarez D, Gómez-Garduño A, Gómez-Delgado F, et al. Mediterranean diet, moderate-to-high intensity training, and health-related quality of life in adults with metabolic syndrome. Eur J Prev Cardiol. 2013;20(4):555–564.
46. Park HS, Sim SJ, Park JY. Effects of weight reduction on metabolic syndrome in Korean obese patients. J Korean Med Sci. 2004;19(2):202–209.
47. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446.
48. Madero M, Arriaga JC, Jalal D, Rivard C, McFann K, Pérez-Méndez O, et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism. 2011;60(11):1551–1559.
49. Zhang JP, Pozuelo L, Brennan DM, Hoar B, Hoogwerf BJ. Association of SF-36 with coronary artery disease risk factors and mortality: a PreCIS study. Prev Cardiol. 2010;13(3):122–129.
50. The British Heart Foundation Global Heart & Circulatory Diseases Factsheet. [(accessed on 10 March 2024)]. Available online: https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-cvd-statistics-global-factsheet.pdf.
51. World Obesity Federation World Obesity Atlas 2024. [(accessed on 10 April 2024)]. Available online: https://data.worldobesity.org/publications/?cat=22.
52. Lin X., Xu Y., Pan X., Xu J., Ding Y., Sun X., Song X., Ren Y., Shan P.F. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci. Rep. 2020;10:14790. doi: 10.1038/s41598-020-71908-9.
53. World Health Organization WHO Acceleration Plan to Stop Obesity. [(accessed on 21 November 2023)]. Available online: https://www.who.int/publications/i/item/9789240075634.
54. World Health Organization Obesity and Overweight. [(accessed on 10 April 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
55. Recalde M., Pistillo A., Viallon V., Fontvieille E., Duarte-Salles T., Freisling H. Body mass index and incident cardiometabolic conditions in relation to obesity-related cancer risk: A population-based cohort study in Catalonia, Spain. Cancer Med. 2023;12:20188–20200. doi: 10.1002/cam4.6603.
56. Lauby-Secretan B., Scoccianti C., Loomis D., Grosse Y., Bianchini F., Straif K. Body Fatness and Cancer—Viewpoint of the IARC Working Group. N. Engl. J. Med. 2016;375:794–798. doi: 10.1056/NEJMsr1606602.
57. World Cancer Research Fund/American Institute for Cancer Research . Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. World Cancer Research Fund International; London, UK: 2018. Continuous Update Project Expert Report.
58. Puhl R.M., Lessard L.M., Himmelstein M.S., Foster G.D. The roles of experienced and internalized weight stigma in healthcare experiences: Perspectives of adults engaged in weight management across six countries. PLoS ONE. 2021;16:e0251566. doi: 10.1371/journal.pone.0251566.
59. Wu Y.K., Berry D.C. Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: A systematic review. J. Adv. Nurs. 2018;74:1030–1042. doi: 10.1111/jan.13511.
60. World Health Organization Declaration of Alma Ata. International Conference on Primary Health Care, Alma-Ata, USSR, 6–12 September 1978. [(accessed on 12 April 2024)]. Available online: https://www.who.int/docs/default-source/documents/almaata-declaration-en.pdf.
61. World Health Organization WHO Package of Essential Noncommunicable (WHO PEN) Disease Interventions for Primary Health Care. [(accessed on 21 September 2023)]. Available online: https://www.who.int/publications/i/item/9789240009226.
62. Tandan M., Dunlea S., Cullen W., Bury G. Teamwork and its impact on chronic disease clinical outcomes in primary care: A systematic review and meta-analysis. Public Health. 2024;229:88–115. doi: 10.1016/j.puhe.2024.01.019.
63. Semlitsch T., Stigler F.L., Jeitler K., Horvath K., Siebenhofer A. Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines. Obes. Rev. 2019;20:1218–1230. doi: 10.1111/obr.12889.
64. Griffin C.D. A Primary Care Nursing Perspective on Chronic Disease Prevention and Management. Del. J. Public Health. 2017;3:78–83. doi: 10.32481/djph.2017.03.011.
65. Centers for Medicare and Medicaid Services. Decision memo for intensive behavioral therapy for obesity (CAG-00423N); 2011. Available from: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&&NcaName=Intensive%20Behavioral%20Therapy%20for%20Obesity&NCAId=253. Accessed 9 July 2023.
66. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP) Description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171. doi: 10.2337/diacare.25.12.2165.
67. Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, et al. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring). 2009;17(4):713–722. doi: 10.1038/oby.2008.637.
68. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–1486. doi: 10.2337/dc10-2415.
69. Knwoer WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi: 10.1056/NEJMoa012512.
70. Haywood C, Sumithran P. Treatment of obesity in older persons—a systematic review. Obes Rev. 2019;20(4):588–598. doi: 10.1111/obr.12815.
71. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(15):1492. doi: 10.1056/NEJMc1701944.
72. Jensen MD, Ryan DH, Donato KA, Apovian CM, Ard JD, Comuzzie AG, et al. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(S2):S1–S410.
73. Wadden TA, Tsai AG, Tronieri JS. A protocol to deliver intensive behavioral therapy (IBT) for obesity in primary care settings: the MODEL-IBT program. Obesity (Silver Spring). 2019;27(10):1562–1566. doi: 10.1002/oby.22594.
74. Garvey WT. New horizons: a new paradigm for treating to target with second-generation obesity medications. J Clin Endocrinol Metab. 2022;107(4):e1339–e1347. doi: 10.1210/clinem/dgab848.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
